Navigation Links
Source of molecular triggers in cutaneous T cell lymphoma identified

In a study published in the journal Blood, Yale scientists identify the molecular triggers that stimulate Cutaneous T Cell Lymphoma (CTCL) cells to clonally expand into large populations of malignant lymphocytes.

CTCL is the most common adult malignancy of T lymphocytes, the white blood cells of the immune system. Finding CTCL triggering factors has been a major goal of Richard L. Edelson, M.D., Director of the Yale Cancer Center, and professor and chair of dermatology at Yale, since he and his colleagues at the National Cancer Institute first identified CTCL as a separate category of lymphoma thirty years ago.

The Yale research group reported that, like all T cells, the cancerous CTCL cells require antigenic stimuli delivered by specialized dendritic cells of the epidermis, referred to as Langerhans cells (LC), in order to replicate.

To determine the nature of the activating antigen, Carole Berger, a research scientist in dermatology set up a physiologic laboratory system mimicking the tight relationship in vivo between CTCL cells and LC. The research team considered three broad categories of antigen as the source of the signal: the protein products of tumor viruses, of mutated genes, and of normal but usually inactive genes.

The study reports that CTCL develops from a small subset of lymphocytes that are pre-programmed to respond to self-antigens exposed during normal cell death. As cells undergo the process of apoptosis, cryptic -- or masked -- antigens, are uncovered. Those newly available antigens are presented by LC directly to CTCL receptors, stimulating the malignant cells rapidly divide.

"This finding has broad implications for the understanding, diagnosis, and treatment of CTCL, as well as potentially contributing to the investigation of other types of lymphomas," said Edelson. "It may now be possible to identify specific antigens and target the malignant cells with selective poisons delivered through the vehicle of L C."

The study also showed that CTCL cells, after stimulation by LC, become functioning regulatory T (Treg) cells that suppress the immune responses of normal T cells to microbial agents. This may explain the susceptibility of patients with extensive CTCL to opportunistic infections.

"Through understanding T cell and dendritic cell interactions, we may gain the ability to manage a spectrum of maladies ranging from cancer to disorders of immune regulation," said Edelson. "Inhibiting Treg-cell generation may be useful for cancer immunotherapy and promoting Treg development may be useful to induce tolerance in autoimmune disease and transplantation,"


'"/>

Source:Yale University


Related biology news :

1. Finding Cures For Tropical Diseases: Is Open Source An Answer?
2. Placenta Is A Rich Source Of Blood Stem Cells
3. Open Source Biotechnology alliance for international agriculture
4. Source of crucial immune cell in the skin discovered
5. Scientists ID molecular switch in liver that triggers harmful effects of saturated and trans fats
6. Plants, animals share molecular growth mechanisms
7. NYU researchers simulate molecular biological clock
8. Scientists reveal molecular secrets of the malaria parasite
9. Scientists identify molecular events that drive cell senescence
10. Researchers discover molecular mechanism that desensitizes us to cold
11. Findings have implications for tracking disease, drugs at the molecular level
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/13/2018)... ... ... New research by Florida Polytechnic University faculty and students has the goal ... the main causes of car accidents and fatalities on the roads. ... of computer science, uses a microcomputer, a camera, and a buzzer. The camera aims ...
(Date:12/10/2018)... ... December 10, 2018 , ... Today, ... advance their shared goal of accelerating the development of the Regenerative Medicine field. ... to TRT’s core technology around human umbilical cord perivascular cells (HUCPVCs). Together, ...
(Date:12/5/2018)... ... December 05, 2018 , ... ... Photodynamic Therapy symposium 2018, London, England. The 2018 PDT symposium was organized by ... PDT and its benefits in clinical practice across a range of applications in ...
Breaking Biology News(10 mins):
(Date:12/13/2018)... ... 2018 , ... Researchers at Worcester Polytechnic Institute (WPI) are ... difficile (C. diff), a dangerous and sometimes fatal gastrointestinal infection. The sensor is ... onsite in doctor’s offices and nursing homes, providing results in minutes instead of ...
(Date:12/5/2018)... ... , ... Leading authority on how to bridge the gap between online and ... Playbook: How to Increase Sales with Proven Networking Strategies.” In honor of ... Foundation of America (AFA). , Itzkowich is hosting “The Referral Playbook” signing event ...
(Date:11/28/2018)... ... ... Earlier this month, Lajollacooks4u's Founder and Chef Jodi Abel traveled to Italy ... season. , Her first stop was Umbria, a region in Central Italy ... Lodge in the small mountain village of Pettino, Chef Jodi was introduced to her ...
(Date:11/20/2018)... ... , ... Each year Forbes receives thousands of nominations for candidates wishing to ... individuals under 30 years of age. The Forbes 30 Under 30 list showcases the ... Venture Capital and Science. , In 2017, Visikol CEO Dr. Michael Johnson was ...
Breaking Biology Technology: